Table III.

Clinical trials of anticoagulation in COVID‐19 with 200 or more participants listed on the clinicaltrials.gov website on 19^th September 2020.

Study and trial Number	Location	Expected participant number	Enrolment start	Estimated end
RAPID COVID‐COAG NCT04362085	Canada	462	May 2020	December 2020
A Randomized Trial of Anticoagulation Strategies in COVID‐19 NCT04359277	USA	1000	April 2020	April 2021
INSPIRATION NCT04486508	Iran	600	July 2020	December 2020
COVID‐HEP NCT04345848	Switzerland	200	April 2020	November 2020
RAPID‐BRAZIL NCT04444700	Brazil	462	July 2020	December 2020
ACTION NCT04394377	Brazil	600	June 2020	December 2020
HEP‐COVID NCT04487990	USA	308	April 2020	April 2021
Antithrombotic Strategies in Hospitalized Adults With COVID‐19 NCT04505774	USA	2000	September 2020	December 2021
COVID‐PACT NCT04409834	USA	750	August 2020	May 2021
REMAP‐CAP NCT02735707	Global	7100	April 2020	December 2023
ATTACC NCT04372589	North, Central and South America	3000	May 2020	January 2021
CORIMMUNO‐COAG NCT04344756	France	808	April 2020	September 2010
COVI‐DOSE NCT04373707	France	602	May 2020	October 2020
X‐COVID‐19	Italy	2712	May 2020	November 2020